Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Immunodeficient rodent

A technology for mice and rodents, applied in blood/immune system cells, biochemical equipment and methods, animal husbandry, etc., can solve the problems of rodents and other problems

Pending Publication Date: 2021-11-05
CENT INST FOR EXPERIMENTAL ANIMALS
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are only small amounts of human eosinophils and human basophils differentiated in any mouse species, and there is no rodent that can maintain sufficient amounts for a long time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immunodeficient rodent
  • Immunodeficient rodent
  • Immunodeficient rodent

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0086] The present invention includes a method for preparing a knock-in rodent obtained by knocking in the human G-CSF gene, the method comprising the step of knocking the human G-CSF gene into the G-CSF receptor locus of the rodent.

[0087] Also included is a method for producing a rodent that is the G-CSF receptor locus of the rodent by transplanting human HSCs into a knock-in rodent obtained by knocking in the human G-CSF gene Knock-in rodents in which the human G-CSF gene was knocked in were transplanted with human HSCs that differentiated and circulated human neutrophils in the periphery.

[0088] The present invention also includes a knock-in rodent obtained by knocking in the human G-CSF gene in the G-CSF receptor locus of the rodent, transplanted with human HSC, and peripherally differentiating and circulating human neutrophils .

[0089] In the present invention, rodents are not limited, and examples thereof include mice, rats, guinea pigs, hamsters, rabbits, nutria...

Embodiment 1

[0144] Example 1: Human G-CSF knock-in mice differentiated from human neutrophils

[0145] 1. Preparation of KI targeting carrier

[0146] The human G-CSF gene is arranged downstream of the cytomegalovirus (CMV) promoter as a systemic expression promoter adjacently, and the homologous sequence 3.3Kb upstream and 6.5Kb downstream of the mouse G-CSF receptor region is clamped Hold, prepare KI targeting carrier. The structure of the targeting vector is shown in figure 1 middle.

[0147] 2. Preparation of human G-CSF knock-in mice

[0148] Electroporate NOG mouse ES cells with the targeting vector prepared above to establish homologous recombination ES cells, then prepare chimeric mice, and then establish F1 mice by mating with NOG mice, and use PCR Analysis of G-CSF receptor gene. figure 2 The results of genetic analysis are shown in . The established mouse system is formally known as NOD.Cg-Prkdc scid Il2rg tm1Sug wxya tm1(CMV-CSF3) / Jic, the official strain name, abbr...

Embodiment 2

[0183] Example 2: Hyperactivity of human neutrophils by mating with FcR KO mice

[0184] FcRKO mice lacking Fcer1g and Fcgr2b, which are constituent molecules of receptors that bind to the Fc region of antibodies, have been established (Inoue Y et al., Journal of Immunology 2007; 179:764-774.). The newly established hG-CSF KI, FcR KO mice obtained by mating this FcR KO mice with hG-CSF KI mice were transplanted with human hematopoietic stem cells, and the results showed that the human leukocytes in the peripheral blood of the mice The proportion of human neutrophils in hG-CSF KI mice was about 2 to 5%, whereas in hG-CSF KI, FcR KO mice, it increased about 4 times to 15 to 20% ( Figure 19 ). Neutrophils differentiate from hematopoietic stem cells in a G-CSF-dependent manner in the bone marrow, and in response to stimuli such as infection, hyperdifferentiate, and at the same time rapidly migrate to the site where the stimuli entered, thereby being able to eliminate bacteria. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The purpose of the present invention is to provide a humanized mouse that enables the long-term survival of human hematopoietic stem cells. The present invention is a humanized rodent in which human neutrophils circulate peripherally, and is obtained by transplanting human hematopoietic cells into a human G-CSF gene knocked-in rodent that expresses human G-CSF and does not express rodent G-CSF receptor. The human G-CSF gene knocked-in rodent is an immunodeficient rodent in which a human G-CSF gene has been knocked into the G-CSF receptor gene locus and the function of the G-CSF receptor has been lost.

Description

technical field [0001] The present invention relates to rodents capable of recapitulating the natural immune system of humans. Background technique [0002] NOG mice are known as very excellent immunodeficiency mice (Patent Document 1). Humanized NOG mice can be prepared by transplanting human cells and tissues into NOG mice. In order to reproduce the natural human immune system, mice in which human granulocytes such as human neutrophils circulate in the periphery for a long time are required. For this purpose, there are mice transplanted with human hematopoietic stem cells and administered with human G-CSF protein (Non-Patent Documents 1 and 2), but the implantation of human neutrophils is temporary, and the mouse phenotype Neutrophils also increase, and therefore, the inability to specialize into a person's natural immune system becomes a major problem. [0003] In addition, eosinophils and basophils are natural immune system cells related to allergic diseases. Human e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/877A01K67/027C12N5/0789C12N15/24C12N15/27
CPCA01K67/0278A01K67/0275A01K2207/15A01K2217/072A01K2227/105A01K2267/0337A01K2267/03C07K14/535C07K14/5403C07K14/5409C07K14/70535C12N15/8775
Inventor 伊藤亮治
Owner CENT INST FOR EXPERIMENTAL ANIMALS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products